Keith McNeil

Summary

Country: Australia

Publications

  1. doi request reprint The BiVACOR rotary biventricular assist device: concept and in vitro investigation
    Daniel Timms
    Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia
    Artif Organs 32:816-9. 2008
  2. doi request reprint Atrial versus ventricular cannulation for a rotary ventricular assist device
    Daniel Timms
    The Prince Charles Hospital, Critical Care Research Group, Chermside, Brisbane, Queensland, Australia
    Artif Organs 34:714-20. 2010
  3. pmc The pulmonary physician in critical care. 13: the pulmonary circulation and right ventricular failure in the ITU
    K McNeil
    Pulmonary Vascular Diseases Unit, Papworth Hospital, Cambridge, UK
    Thorax 58:157-62. 2003
  4. ncbi request reprint Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients
    Keith McNeil
    Head of Transplant Services, The Prince Charles Hospital, Chermside, Queensland, Australia
    Transplantation 81:998-1003. 2006
  5. ncbi request reprint Is obliterative bronchiolitis in lung transplantation associated with microvascular damage to small airways?
    Heyman Luckraz
    Transplant Unit, Papworth Hospital, Papworth Everard, Cambridge, United Kingdom
    Ann Thorac Surg 82:1212-8. 2006
  6. doi request reprint Evidence for immunosuppression in lung transplantation
    Peter M Hopkins
    Queensland Centre for Thoracic Transplantation, The Prince Charles Hospital, Chermside, Brisbane, Queensland, Australia
    Curr Opin Organ Transplant 13:477-83. 2008
  7. ncbi request reprint Graft-versus-host disease in lung transplantation: 4 case reports and literature review
    Heyman Luckraz
    Transplant Unit, Papworth Hospital, Cambridge, UK
    J Heart Lung Transplant 22:691-7. 2003
  8. doi request reprint Oil red O stain of alveolar macrophages is an effective screening test for gastroesophageal reflux disease in lung transplant recipients
    Peter M Hopkins
    Queensland Centre for Pulmonary Transplantation and Vascular Disease, Prince Charles Hospital, Chermside, Brisbane, Australia
    J Heart Lung Transplant 29:859-64. 2010
  9. ncbi request reprint Microvascular changes in small airways predispose to obliterative bronchiolitis after lung transplantation
    Heyman Luckraz
    Transplant Unit, Papworth Hospital, Cambridge, UK
    J Heart Lung Transplant 23:527-31. 2004
  10. pmc Chronic thromboembolic pulmonary hypertension (CTEPH)
    Keith McNeil
    The Prince Charles Hospital, Chermside, Queensland, Australia
    Heart 93:1152-8. 2007

Collaborators

Detail Information

Publications21

  1. doi request reprint The BiVACOR rotary biventricular assist device: concept and in vitro investigation
    Daniel Timms
    Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia
    Artif Organs 32:816-9. 2008
    ..The in vitro results encourage device progression to in vivo animal studies. Successful development of this BiVAD will provide a suitably miniature device for patients who require biventricular assistance...
  2. doi request reprint Atrial versus ventricular cannulation for a rotary ventricular assist device
    Daniel Timms
    The Prince Charles Hospital, Critical Care Research Group, Chermside, Brisbane, Queensland, Australia
    Artif Organs 34:714-20. 2010
    ..AC is therefore more suitable for class III, bridge to recovery patients, while VC is appropriate for class IV, bridge to transplant/destination patients...
  3. pmc The pulmonary physician in critical care. 13: the pulmonary circulation and right ventricular failure in the ITU
    K McNeil
    Pulmonary Vascular Diseases Unit, Papworth Hospital, Cambridge, UK
    Thorax 58:157-62. 2003
    ..The management of severe pulmonary hypertension associated with right ventricular failure is reviewed and its relevance to adults with acute respiratory distress syndrome (ARDS) is discussed...
  4. ncbi request reprint Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients
    Keith McNeil
    Head of Transplant Services, The Prince Charles Hospital, Chermside, Queensland, Australia
    Transplantation 81:998-1003. 2006
    ..This study attempted to determine whether MMF reduces the incidence of BOS in de novo lung transplant recipients compared with azathioprine (AZA)...
  5. ncbi request reprint Is obliterative bronchiolitis in lung transplantation associated with microvascular damage to small airways?
    Heyman Luckraz
    Transplant Unit, Papworth Hospital, Papworth Everard, Cambridge, United Kingdom
    Ann Thorac Surg 82:1212-8. 2006
    ....
  6. doi request reprint Evidence for immunosuppression in lung transplantation
    Peter M Hopkins
    Queensland Centre for Thoracic Transplantation, The Prince Charles Hospital, Chermside, Brisbane, Queensland, Australia
    Curr Opin Organ Transplant 13:477-83. 2008
    ..The purpose of this review is to summarize the evidence for immunosuppressive regimens in the prevention and treatment of lung allograft rejection...
  7. ncbi request reprint Graft-versus-host disease in lung transplantation: 4 case reports and literature review
    Heyman Luckraz
    Transplant Unit, Papworth Hospital, Cambridge, UK
    J Heart Lung Transplant 22:691-7. 2003
    ..It is associated with significant morbidity and a high mortality rate. We describe 4 cases of GVHD encountered over a 17-year period and review the literature about this peculiar pathology...
  8. doi request reprint Oil red O stain of alveolar macrophages is an effective screening test for gastroesophageal reflux disease in lung transplant recipients
    Peter M Hopkins
    Queensland Centre for Pulmonary Transplantation and Vascular Disease, Prince Charles Hospital, Chermside, Brisbane, Australia
    J Heart Lung Transplant 29:859-64. 2010
    ..In this study we aimed to assess the utility of the lipid index in identifying patients with significant GORD...
  9. ncbi request reprint Microvascular changes in small airways predispose to obliterative bronchiolitis after lung transplantation
    Heyman Luckraz
    Transplant Unit, Papworth Hospital, Cambridge, UK
    J Heart Lung Transplant 23:527-31. 2004
    ..Moreover, there has been no study of the microcirculation in the small airways in lung transplantation. This study assesses the microvasculature around small airways (SA) in post-mortem lung allograft specimens...
  10. pmc Chronic thromboembolic pulmonary hypertension (CTEPH)
    Keith McNeil
    The Prince Charles Hospital, Chermside, Queensland, Australia
    Heart 93:1152-8. 2007
  11. ncbi request reprint Cytomegalovirus antibody status of donor/recipient does not influence the incidence of bronchiolitis obliterans syndrome in lung transplantation
    Heyman Luckraz
    Transplant Unit, Papworth Hospital, Cambridge, UK
    J Heart Lung Transplant 22:287-91. 2003
    ..The aim of this study is to determine the incidence of BOS in lung transplant patients with CMV-antibody-negative (-) donors (D) and recipients (R), and to evaluate the risk factors that predispose to BOS in this sub-group...
  12. ncbi request reprint Fast track recovery following en bloc heart-lung-liver transplantation in a patient with cystic fibrosis complicated by severe portal hypertension
    Igor E Konstantinov
    Division of Cardiothoracic Surgery, The Prince Charles Hospital, Rode Road, Chermside, Brisbane, Qld 4032, Australia
    Heart Lung Circ 17:154-6. 2008
    ..An early extubation with an aggressive physiotherapy made an early ambulation feasible and contributed to an early discharge from the hospital...
  13. ncbi request reprint Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities?
    Christopher H Jackson
    MRC Biostatistics Unit, University Forvie Site, Cambridge, UK
    J Heart Lung Transplant 21:658-66. 2002
    ..Potential causes of BOS include sub-clinical chronic rejection and/or exaggerated healing response following acute injury. BOS may thus result from two or more distinct processes, both acute and chronic...
  14. doi request reprint Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus
    Peter Hopkins
    Department of Respiratory Medicine, The Prince Charles Hospital, Rode Road, Chermside, Brisbane, Australia 4032
    Am J Respir Crit Care Med 178:876-81. 2008
    ..Human metapneumovirus is a newly described virus isolated in 2001 from children with acute respiratory viral infection. It has subsequently been reported globally, although there are limited data in lung transplant recipients...
  15. doi request reprint Narrowing of T-cell receptor beta variable repertoire during symptomatic herpesvirus infection in transplant patients
    Katherine K Wynn
    Australian Centre for Vaccine Development, and Tumour Immunology Laboratory, Department of Infectious Diseases, Queensland Institute of Medical Research, Brisbane, Queensland, Australia
    Immunol Cell Biol 88:125-35. 2010
    ....
  16. ncbi request reprint The incidence of end-stage renal failure in 17 years of heart transplantation: a single center experience
    Duwarakan K Satchithananda
    Transplant Unit, Papworth Hospital, Everard, Cambridge, United Kingdom
    J Heart Lung Transplant 21:651-7. 2002
    ..We report a single-center experience of end-stage renal failure (ESRF) during a 17-year period encompassing current lower dose CsA regimens...
  17. ncbi request reprint Eleven years on: a clinical update of key areas of the 1996 lung allograft rejection working formulation
    Gregory I Snell
    Alfred Hospital, Melbourne, Australia
    J Heart Lung Transplant 26:423-30. 2007
  18. ncbi request reprint Interleukin 1 and chronic rejection: possible genetic links in human heart allografts
    Joannis E Vamvakopoulos
    University of Cambridge, Department of Surgery, Addenbrooke s Hospital, UK
    Am J Transplant 2:76-83. 2002
    ..This case-control study indicates that gene polymorphisms which influence IL1 bioactivity also influence the progression of chronic rejection in heart grafts...
  19. ncbi request reprint Risk factors for bronchiolitis obliterans: a systematic review of recent publications
    Linda D Sharples
    Medical Research Council MRC Biostatistics Unit, University Forvie Site, Papworth Everard, Cambridge, United Kingdom
    J Heart Lung Transplant 21:271-81. 2002
    ..A thorough understanding of the factors that confer high risk of developing obliterative bronchiolitis or its physiologic surrogate bronchiolitis obliterans syndrome is important to help define therapeutic strategies...
  20. pmc Review of bosentan in the management of pulmonary arterial hypertension
    Eli Gabbay
    Western Australian Lung Transplant Unit and Pulmonary Hypertension Service, Royal Perth Hospital, Western Australia, Australia
    Vasc Health Risk Manag 3:887-900. 2007
    ..Finally, the role of bosentan as part of combination therapy in PAH is examined...
  21. ncbi request reprint Use of 18FDG-pet to discriminate between infection and rejection in lung transplant recipients
    Hazel A Jones
    Respiratory Medicine, Imperial College London, Hammersmith Campus, London, United Kingdom
    Transplantation 77:1462-4. 2004
    ..This non-invasive and repeatable test could reduce the number of transbronchial biopsies required during episodes of breathlessness after lung transplantation...